作者：
Yunlin,Zhang [1]
;
Ruchi P,Patel [2]
;
Ki Hyun,Kim [1]
;
Hyungwoo,Cho [2]
;
Jae-Cheol,Jo [3]
;
Seong Hyun,Jeong [4]
;
Sung Yong,Oh [5]
;
Yoon Seok,Choi [6]
;
Sung Hyun,Kim [7]
;
Ji Hyun,Lee [6]
;
Mathew,Angelos [7]
;
Puneeth,Guruprasad [7]
;
Ivan,Cohen [1]
;
Ositadimma,Ugwuanyi [2]
;
Yong Gu,Lee [1]
;
Raymone,Pajarillo [2]
;
Jong Hyun,Cho [1]
;
Alberto,Carturan [2]
;
Luca,Paruzzo [1]
;
Guido,Ghilardi [2]
;
Michael,Wang [1]
;
Soohwan,Kim [2]
;
Sung-Min,Kim [8]
;
Hyun-Jong,Lee [1]
;
Ji-Ho,Park [2]
;
Leiguang,Cui [9]
;
Tae Bum,Lee [1]
;
In-Sik,Hwang [2]
;
Young-Ha,Lee [1]
;
Yong-Jun,Lee [2]
;
Patrizia,Porazzi [1]
;
Dongfang,Liu [2]
;
Yoon,Lee [1]
;
Jong-Hoon,Kim [2]
;
Jong-Seo,Lee [3]
;
Dok Hyun,Yoon [3]
;
Junho,Chung [3]
;
Marco,Ruella [3]
作者单位：
Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Boulevard, Perelman Center for Advanced Medicine, SPE 8-112, Philadelphia, PA, 19104, USA.
[1]
Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
[2]
Biopharmaceutical Research Center, AbClon Inc., #1401, Ace Twin Tower1, 285 Digital-Ro, Guro-Gu, Seoul, Korea.
[3]
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-Gu, Seoul, Korea.
[4]
Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
[5]
Ajou University Hospital, Suwon, Korea.
[6]
Division of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
[7]
College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Korea.
[8]
Department of Pathology, Immunology and Laboratory Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
[9]
Biopharmaceutical Research Center, AbClon Inc., #1401, Ace Twin Tower1, 285 Digital-Ro, Guro-Gu, Seoul, Korea. jslee@abclon.com.
[10]
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-Gu, Seoul, Korea. dhyoon@amc.seoul.kr.
[11]
Cancer Research Institute, Seoul National University College of Medicine, Suite 510, Samsung Cancer Research Building, 103 Daehak-Ro, Jongno-Gu, Seoul, Korea. jjhchung@snu.ac.kr.
[12]
Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Boulevard, Perelman Center for Advanced Medicine, SPE 8-112, Philadelphia, PA, 19104, USA. mruella@upenn.edu.
[13]
Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.
[14]
Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.
[15]
主题词
人类(Humans);抗体(Antibodies);抗原, CD19(Antigens, CD19);表位(Epitopes);免疫疗法, 过继(Immunotherapy, Adoptive);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);肿瘤复发, 局部(Neoplasm Recurrence, Local);受体, 抗原, T细胞(Receptors, Antigen, T-Cell)
DOI
10.1186/s12943-023-01886-9
PMID
38066564
发布时间
2024-06-15
换一批
换一批
